Cboe Global Markets, Inc. · CBOE · FY2024 Q2 · Calendar Q3 2024
Cboe raises growth outlook as derivatives demand stays strong
The quarter supports a constructive operating thesis: strong derivatives demand, product expansion, international growth, and organic execution are supporting higher growth guidance. The evidence is positive, but the thesis depends on new-product adoption, a rebound in Data & Access Solutions timing, and regulatory execution.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about CBOE FY2024 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Cboe reported record Q2 revenue and 21% EPS growth, raised full-year organic net revenue growth guidance to 6%-8%, and emphasized organic growth over M&A. New information included planned VIX futures options and variance futures launches, broader technology deployment, and additional international partnerships.
Guidance delta
Management raised full-year organic net revenue growth guidance from the prior quarter's higher end of 5%-7% range to 6%-8%.
Key takeaways
- Q2 delivered record $514 million in net revenue, up 10% year over year, with adjusted EPS up 21% to $2.15.
- Derivatives demand was strong, particularly in SPX index options and VIX products.
- Data & Access Solutions growth slowed temporarily because of timing, while management expects a rebound.
- Cboe is prioritizing organic initiatives over M&A and continuing capital returns.
- International expansion and new volatility products are central to the next phase of growth.
Management priorities
- Expand SPX, VIX and variance-futures products, subject to regulatory review.
- Continue technology investment through dedicated cores and Cboe Global Cloud.
- Grow international broker partnerships in APAC and Europe.
- Maintain organic investment alongside share repurchases and dividends.
Follow CBOE with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 25, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Oct 14, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 12, 2026 |
| Morgan Stanley | Overweight | Underweight | Upgrade | Oct 9, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 7, 2026 |
| Goldman Sachs | Neutral | Sell | Upgrade | Oct 2, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | Jul 28, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 15, 2026 |
| UBS | Neutral | Neutral | Maintain | May 4, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | May 4, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Nov 3, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | Aug 4, 2025 |
| B of A Securities | Neutral | Buy | Downgrade | Apr 10, 2025 |
| Jefferies | Hold | Hold | Maintain | Jan 9, 2025 |
| Deutsche Bank | Buy | Hold | Upgrade | Nov 11, 2024 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Nov 4, 2024 |
| Rosenblatt | Buy | Buy | Maintain | May 6, 2024 |
| Argus Research | Hold | Buy | Downgrade | Nov 16, 2023 |
| Credit Suisse | Outperform | Neutral | Upgrade | Jan 5, 2023 |
| Compass Point | Buy | Neutral | Upgrade | Oct 7, 2021 |
| CFRA | Strong Buy | Buy | Upgrade | Feb 28, 2020 |
| Bank of America | Underperform | Buy | Downgrade | Sep 13, 2019 |
| Raymond James | Market Perform | Outperform | Downgrade | Jun 11, 2019 |
| MKM Partners | Overweight | Neutral | Upgrade | Feb 25, 2019 |
| Evercore ISI Group | Buy | Hold | Upgrade | Oct 10, 2016 |
| Keefe Bruyette & Woods | Market Perform | Market Perform | Maintain | Sep 27, 2016 |
| Buckingham Research | Buy | Neutral | Upgrade | Sep 27, 2016 |
| CLSA | Underperform | Outperform | Downgrade | Feb 8, 2016 |
| Stifel Nicolaus | Market Perform | Market Perform | Maintain | Aug 3, 2015 |
| Stifel | Market Perform | Market Perform | Maintain | Aug 3, 2015 |
| S&P Capital IQ | Strong Buy | Hold | Upgrade | Jan 28, 2014 |
| Macquarie | Outperform | Neutral | Upgrade | Oct 29, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $340.42. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $450 | $327.72 | +32.2% | Oct 23, 2026 |
| Wells Fargo | Analyst unavailable | $309 | $292.25 | -9.2% | Oct 14, 2026 |
| Morgan Stanley | Michael Cyprys | $358 | $294.08 | +5.2% | Oct 9, 2026 |
| Loop Capital Markets | Analyst unavailable | $343 | $278.2 | +0.8% | Oct 7, 2026 |
| Loop Capital Markets | Analyst unavailable | $334 | $271.26 | -1.9% | Oct 5, 2026 |
| Loop Capital Markets | Analyst unavailable | $300 | $277.19 | -11.9% | Oct 2, 2026 |
| Goldman Sachs | Alexander Blostein | $300 | $277.19 | -11.9% | Oct 2, 2026 |
| Wells Fargo | Analyst unavailable | $301 | $277.19 | -11.6% | Oct 1, 2026 |
| Loop Capital Markets | Eli Abboud | $356 | $289.08 | +4.6% | Aug 5, 2026 |
| Loop Capital Markets | Analyst unavailable | $315 | $299.28 | -7.5% | Aug 3, 2026 |
| Loop Capital Markets | Benjamin Budish | $354 | $310.23 | +4.0% | Aug 3, 2026 |
| Loop Capital Markets | Analyst unavailable | $380 | $310.23 | +11.6% | Aug 3, 2026 |
| Loop Capital Markets | Analyst unavailable | $288 | $288.87 | -15.4% | Jul 28, 2026 |
| Loop Capital Markets | Analyst unavailable | $304 | $274.04 | -10.7% | Jul 20, 2026 |
| Piper Sandler | Patrick Moley | $320 | $274.98 | -6.0% | Jul 15, 2026 |
| Morgan Stanley | Michael Cyprys | $258 | $267.92 | -24.2% | Jul 10, 2026 |
| Loop Capital Markets | Analyst unavailable | $347 | $263.86 | +1.9% | Jul 9, 2026 |
| Loop Capital Markets | Analyst unavailable | $263 | $250.96 | -22.7% | Jun 22, 2026 |
| Redburn Partners | Analyst unavailable | $316 | $301.08 | -7.2% | Jun 11, 2026 |
| Loop Capital Markets | Analyst unavailable | $340 | $339.36 | -0.1% | May 4, 2026 |
| UBS | Analyst unavailable | $335 | $338.76 | -1.6% | May 4, 2026 |
| Loop Capital Markets | Analyst unavailable | $395 | $335.05 | +16.0% | May 4, 2026 |
| Loop Capital Markets | Analyst unavailable | $365 | $337.25 | +7.2% | May 4, 2026 |
| Loop Capital Markets | Analyst unavailable | $335 | $326.96 | -1.6% | May 4, 2026 |
| Loop Capital Markets | Analyst unavailable | $382 | $326.96 | +12.2% | May 4, 2026 |
| Piper Sandler | Analyst unavailable | $321 | $300.75 | -5.7% | Apr 15, 2026 |
| Morgan Stanley | Michael Cyprys | $273 | $294.04 | -19.8% | Apr 10, 2026 |
| Loop Capital Markets | Analyst unavailable | $293 | $294.82 | -13.9% | Apr 9, 2026 |
| RBC Capital | Ashish Sabadra | $303 | $275.82 | -11.0% | Feb 9, 2026 |
| UBS | Alex Kramm | $290 | $275.36 | -14.8% | Feb 9, 2026 |
| Loop Capital Markets | Benjamin Budish | $317 | $273.09 | -6.9% | Feb 9, 2026 |
| Loop Capital Markets | Analyst unavailable | $281 | $262.18 | -17.5% | Jan 14, 2026 |
| Piper Sandler | Patrick Moley | $295 | $266.77 | -13.3% | Jan 14, 2026 |
| Loop Capital Markets | Benjamin Budish | $295 | $255.16 | -13.3% | Jan 8, 2026 |
| UBS | Analyst unavailable | $280 | $255.26 | -17.7% | Jan 7, 2026 |
| Morgan Stanley | Analyst unavailable | $240 | $248.05 | -29.5% | Dec 22, 2025 |
| Loop Capital Markets | Analyst unavailable | $302 | $251.33 | -11.3% | Dec 12, 2025 |
| Loop Capital Markets | Analyst unavailable | $310 | $249.82 | -8.9% | Dec 10, 2025 |
| Loop Capital Markets | Analyst unavailable | $269 | $246.1 | -21.0% | Nov 3, 2025 |
| Loop Capital Markets | Analyst unavailable | $265 | $246.1 | -22.2% | Nov 3, 2025 |
| Piper Sandler | Patrick Moley | $290 | $246.1 | -14.8% | Nov 3, 2025 |
| Loop Capital Markets | Analyst unavailable | $273 | $246.1 | -19.8% | Nov 3, 2025 |
| Loop Capital Markets | Analyst unavailable | $287 | $246.1 | -15.7% | Nov 3, 2025 |
| Piper Sandler | Analyst unavailable | $270 | $243.49 | -20.7% | Oct 14, 2025 |
| Loop Capital Markets | Benjamin Budish | $264 | $240.9 | -22.4% | Oct 8, 2025 |
| Loop Capital Markets | Craig Siegenthaler | $261 | $241.76 | -23.3% | Oct 2, 2025 |
| Morgan Stanley | Analyst unavailable | $221 | $241.96 | -35.1% | Oct 1, 2025 |
| RBC Capital | Analyst unavailable | $254 | $250.87 | -25.4% | Aug 4, 2025 |
| UBS | Analyst unavailable | $255 | $250.87 | -25.1% | Aug 4, 2025 |
| Oppenheimer | Analyst unavailable | $265 | $250.87 | -22.2% | Aug 4, 2025 |
| Piper Sandler | Analyst unavailable | $265 | $250.87 | -22.2% | Aug 4, 2025 |
| Morgan Stanley | Michael Cyprys | $218 | $233.95 | -36.0% | Jul 15, 2025 |
| UBS | Alex Kramm | $245 | $231.67 | -28.0% | May 5, 2025 |
| Loop Capital Markets | Kyle Voigt | $227 | $231.67 | -33.3% | May 5, 2025 |
| Loop Capital Markets | Craig Siegenthaler | $260 | $224.48 | -23.6% | Apr 2, 2025 |
| Barclays | Benjamin Budish | $220 | $203.99 | -35.4% | Dec 9, 2024 |
| Deutsche Bank | Brian Bedell | $222 | $213.23 | -34.8% | Nov 11, 2024 |
| Deutsche Bank | Brian Bedell | $212 | $209.6 | -37.7% | Nov 4, 2024 |
| TD Securities | Bill Katz | $205 | $203.1 | -39.8% | Sep 25, 2024 |
| Morgan Stanley | Michael Cyprys | $188 | $196.27 | -44.8% | Aug 6, 2024 |
| Piper Sandler | Richard Repetto | $210 | $194.06 | -38.3% | Aug 5, 2024 |
| Oppenheimer | Owen Lau | $209 | $193.94 | -38.6% | Aug 5, 2024 |
| Loop Capital Markets | Benjamin Budish | $218 | $193.78 | -36.0% | Aug 5, 2024 |
| Loop Capital Markets | Kenneth Worthington | $195 | $193.78 | -42.7% | Aug 5, 2024 |
| Loop Capital Markets | Craig Siegenthaler | $230 | $193.78 | -32.4% | Aug 4, 2024 |
| Loop Capital Markets | Kenneth Worthington | $166 | $170.22 | -51.2% | Jul 12, 2024 |
| Barclays | Benjamin Budish | $215 | $170.92 | -36.8% | Jul 5, 2024 |
| Rosenblatt Securities | Andrew Bond | $205 | $179.67 | -39.8% | May 6, 2024 |
| Loop Capital Markets | Benjamin Budish | $215 | $179.67 | -36.8% | May 6, 2024 |
| Morgan Stanley | Michael Cyprys | $199 | $182.37 | -41.5% | Apr 9, 2024 |
| Deutsche Bank | Brian Bedell | $178 | $181.57 | -47.7% | Apr 5, 2024 |
| Barclays | Benjamin Budish | $204 | $176.4 | -40.1% | Jan 8, 2024 |
| Piper Sandler | Patrick Moley | $174 | $156.2 | -48.9% | Sep 29, 2023 |
| J.P. Morgan | Analyst unavailable | $125 | $123.56 | -63.3% | Jan 9, 2023 |
| Deutsche Bank | Analyst unavailable | $141 | $122.84 | -58.6% | Nov 15, 2022 |
| Loop Capital Markets | Alexander Blostein | $126 | $117.73 | -63.0% | Sep 30, 2022 |
| Credit Suisse | Analyst unavailable | $145 | $123.38 | -57.4% | Aug 1, 2022 |
| Morgan Stanley | Michael Cyprys | $140 | $118.18 | -58.9% | Jul 19, 2022 |
| Deutsche Bank | Analyst unavailable | $136 | $118.11 | -60.0% | Jul 13, 2022 |
| Credit Suisse | Analyst unavailable | $146 | $120.12 | -57.1% | Jul 13, 2022 |
| Deutsche Bank | Analyst unavailable | $131 | $105.59 | -61.5% | May 19, 2022 |
| UBS | Alex Kramm | $124 | $115.86 | -63.6% | Jul 7, 2021 |
| Barclays | Jeremy Campbell | $97 | $102.77 | -71.5% | Apr 30, 2021 |
Track every rating change on CBOE the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCboe Global Markets, Inc. functions as a global operator of various financial exchanges, primarily renowned for its options trading platforms, all managed through its numerous subsidiaries. The company organizes its expansive business activities into five distinct segments. The Options segment specializes in the trading of listed market indices. Its North American Equities division facilitates transactions for listed stocks in the United States and Canada, also offering services for exchange-traded products (ETPs), encompassing both trading and listing. The Futures segment is dedicated to futures trading.…
Historical context
All CBOE earningsFinancial Services peers this season
Latest reports in the same sectorLatest beats and misses
Who reports nextBeat on EPS
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
- FCNCNFY2026 Q3 · October 23, 2026+19.9% EPS+0.2% move
- FCNCOFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- FCNCPFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- RDYFY2027 Q2 · October 23, 2026+24.0% EPS-0.2% move
- SLBFY2026 Q3 · October 23, 2026+3.7% EPS+7.1% move
Missed on EPS
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
- SPOTFY2026 Q3 · October 22, 2026-11.6% EPS+11.1% move
- VRSNFY2026 Q3 · October 22, 2026-2.0% EPS-0.9% move
- HBANMFY2026 Q3 · October 22, 2026-5.3% EPS+0.5% move
Get the CBOE recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-10-17T05:10:49.140638+00:00
- Polygon adjusted daily market bars · 2026-10-24T23:00:43.019797+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-24T23:00:43.016908+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-24. For educational purposes only; not investment advice.